speb/financial-data huggingface dataset:
MD income_statement (quarterly, 2025-12-31) — Normalized Income: 34555455.82
MD cash_flow (annual, 2025-12-31) — Operating Cash Flow: 271091000.00
MD cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 114102000.00
MD cash_flow (annual, 2025-12-31) — Operating Gains Losses: -20906000.00
MD cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 0.00
MD income_statement (annual, 2025-12-31) — Operating Income: 231085000.00
MD income_statement (quarterly, 2025-12-31) — Operating Income: 54673000.00
MD income_statement (annual, 2025-12-31) — Operating Revenue: 1901642000.00
MD income_statement (quarterly, 2025-12-31) — Operating Revenue: 491538000.00
MD balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 82976110.00
MD balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 82976110.00
MD balance_sheet (annual, 2025-12-31) — Other Current Assets: 8879000.00
MD balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 8879000.00
MD balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 25000000.00
MD balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 25000000.00
MD balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 610000.00
MD balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 610000.00
MD income_statement (annual, 2025-12-31) — Other Gand A: 240791000.00
MD income_statement (quarterly, 2025-12-31) — Other Gand A: 65680000.00
MD income_statement (annual, 2025-12-31) — Other Income Expense: 21312000.00
MD income_statement (quarterly, 2025-12-31) — Other Income Expense: -338000.00
MD balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 16862000.00
MD balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 16862000.00
MD cash_flow (annual, 2025-12-31) — Other Non Cash Items: -3627000.00
MD cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -621000.00
MD balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 58156000.00
MD balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 58156000.00
MD balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 268689000.00
MD balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 268689000.00
MD balance_sheet (annual, 2025-12-31) — Other Properties: 195527000.00
MD balance_sheet (quarterly, 2025-12-31) — Other Properties: 195527000.00
MD balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 124482000.00
MD balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 124482000.00
MD balance_sheet (annual, 2025-12-31) — Payables: 77824000.00
MD balance_sheet (quarterly, 2025-12-31) — Payables: 77824000.00
MD balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 420514000.00
MD balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 420514000.00
MD balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
MD balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
MD balance_sheet (annual, 2025-12-31) — Prepaid Assets: 12606000.00
MD balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 12606000.00
MD income_statement (annual, 2025-12-31) — Pretax Income: 216432000.00
MD income_statement (quarterly, 2025-12-31) — Pretax Income: 45595000.00
MD balance_sheet (annual, 2025-12-31) — Properties: 0.00
MD balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
MD cash_flow (annual, 2025-12-31) — Purchase Of Business: -23196000.00
MD cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -4000000.00
MD cash_flow (annual, 2025-12-31) — Purchase Of Investment: -29851000.00
MD cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -6367000.00
MD cash_flow (annual, 2025-12-31) — Purchase Of PPE: -18458000.00
MD cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -5287000.00
MD balance_sheet (annual, 2025-12-31) — Receivables: 242306000.00
MD balance_sheet (quarterly, 2025-12-31) — Receivables: 242306000.00
MD income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1420146000.00
MD income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 367787000.00
MD income_statement (annual, 2025-12-31) — Reconciled Depreciation: 21827000.00
MD income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 5631000.00
MD cash_flow (annual, 2025-12-31) — Repayment Of Debt: -20750000.00
MD cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -5341000.00
MD cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -86683000.00
MD cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -64038000.00
MD income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 22272000.00
MD income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 5879000.00
MD balance_sheet (annual, 2025-12-31) — Retained Earnings: -83152000.00
MD balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -83152000.00
MD cash_flow (annual, 2025-12-31) — Sale Of Business: 30000000.00
MD cash_flow (quarterly, 2025-12-31) — Sale Of Business: 0.00
MD cash_flow (annual, 2025-12-31) — Sale Of Investment: 26674000.00
MD cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 5250000.00
MD income_statement (annual, 2025-12-31) — Selling General And Administration: 240791000.00
MD income_statement (quarterly, 2025-12-31) — Selling General And Administration: 65680000.00
MD balance_sheet (annual, 2025-12-31) — Share Issued: 82976110.00
MD balance_sheet (quarterly, 2025-12-31) — Share Issued: 82976110.00
MD income_statement (annual, 2025-12-31) — Special Income Charges: -1366000.00
MD income_statement (quarterly, 2025-12-31) — Special Income Charges: -5879000.00
MD cash_flow (annual, 2025-12-31) — Stock Based Compensation: 18045000.00
MD cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 5345000.00
MD balance_sheet (annual, 2025-12-31) — Stockholders Equity: 865854000.00
MD balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 865854000.00
MD balance_sheet (annual, 2025-12-31) — Tangible Book Value: -411740000.00
MD balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -411740000.00
MD income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 4168708.20
MD income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -308544.18
MD income_statement (annual, 2025-12-31) — Tax Provision: 51044000.00
MD income_statement (quarterly, 2025-12-31) — Tax Provision: 11912000.00
MD income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.24
MD income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.26
MD balance_sheet (annual, 2025-12-31) — Taxes Receivable: 12641000.00
MD balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 12641000.00
MD balance_sheet (annual, 2025-12-31) — Total Assets: 2246696000.00
MD balance_sheet (quarterly, 2025-12-31) — Total Assets: 2246696000.00
MD balance_sheet (annual, 2025-12-31) — Total Capitalization: 1434807000.00
MD balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 1434807000.00
MD balance_sheet (annual, 2025-12-31) — Total Debt: 634615000.00
MD balance_sheet (quarterly, 2025-12-31) — Total Debt: 634615000.00
MD balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 865854000.00
MD balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 865854000.00
MD income_statement (annual, 2025-12-31) — Total Expenses: 1682764000.00
MD income_statement (quarterly, 2025-12-31) — Total Expenses: 439098000.00
MD balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 1380842000.00
MD balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1380842000.00
MD balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 1483182000.00
MD balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1483182000.00
MD balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 921931000.00
MD balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 921931000.00
MD income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 208813000.00
MD income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 48794000.00
MD balance_sheet (annual, 2025-12-31) — Total Tax Payable: 40604000.00
MD balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 40604000.00
MD income_statement (annual, 2025-12-31) — Total Unusual Items: 17679000.00
MD income_statement (quarterly, 2025-12-31) — Total Unusual Items: -1181000.00
MD income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 17679000.00
MD income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -1181000.00
MD balance_sheet (annual, 2025-12-31) — Working Capital: 304603000.00
MD balance_sheet (quarterly, 2025-12-31) — Working Capital: 304603000.00
MD income_statement (annual, 2025-12-31) — Write Off: 0.00
MD income_statement (quarterly, 2026-03-31) — +Operating Expense: 66385000.00
MD income_statement (quarterly, 2026-03-31) — +Total Revenue: 476196000.00
MD balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 31537000.00
MD balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 224801000.00
MD balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 931258000.00
MD income_statement (quarterly, 2026-03-31) — Basic Average Shares: 82061119.00
MD income_statement (quarterly, 2026-03-31) — Basic EPS: 0.36
MD cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 375241000.00
MD cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -6247000.00
MD balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 38946000.00
MD balance_sheet (quarterly, 2026-03-31) — Capital Stock: 821000.00
MD balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 205780000.00
MD balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 328974000.00
MD cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -27635000.00
MD cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -11979000.00
MD cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -129502000.00
MD cash_flow (quarterly, 2026-03-31) — Cash From Discontinued Operating Activities: -345000.00
MD cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -181467000.00
MD cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: 871000.00
MD cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 4744000.00
MD cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -6675000.00
MD cash_flow (quarterly, 2026-03-31) — Change In Payable: -180596000.00
MD cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -180596000.00
MD cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 34000.00
MD cash_flow (quarterly, 2026-03-31) — Change In Receivables: 4864000.00
MD cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: 871000.00
MD cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -177629000.00
MD cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 4864000.00
MD cash_flow (quarterly, 2026-03-31) — Changes In Cash: -169461000.00
MD balance_sheet (quarterly, 2026-03-31) — Common Stock: 821000.00
MD balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 878576000.00
MD cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 544000.00
MD cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -21451000.00
MD income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 363232000.00
MD balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 180906000.00
MD balance_sheet (quarterly, 2026-03-31) — Current Assets: 587034000.00
MD balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 11885000.00
MD balance_sheet (quarterly, 2026-03-31) — Current Debt: 192421000.00
MD balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 204306000.00
MD balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 442638000.00
MD cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 8342000.00
MD cash_flow (quarterly, 2026-03-31) — Deferred Tax: 8342000.00
MD cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 6119000.00
MD income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 6119000.00
MD cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 6119000.00
MD income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 6119000.00
MD income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 83075000.00
MD income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.36
MD income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 29572000.00
MD income_statement (quarterly, 2026-03-31) — EBIT: 47109000.00
MD income_statement (quarterly, 2026-03-31) — EBITDA: 53228000.00
MD income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: 692000.00
MD cash_flow (quarterly, 2026-03-31) — End Cash Position: 205780000.00
MD cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -27635000.00
MD cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -136094000.00
MD income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 4760000.00
MD balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 77000.00
MD income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 60266000.00
MD balance_sheet (quarterly, 2026-03-31) — Goodwill: 1268248000.00
MD balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 1284185000.00
MD balance_sheet (quarterly, 2026-03-31) — Gross PPE: 77965000.00
MD income_statement (quarterly, 2026-03-31) — Gross Profit: 112964000.00
MD balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 1402000.00
MD income_statement (quarterly, 2026-03-31) — Interest Expense: 8265000.00
MD income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 8265000.00
MD balance_sheet (quarterly, 2026-03-31) — Interest Payable: 2775000.00
MD balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1469345000.00
MD cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -11979000.00
MD cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 544000.00
MD balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 27061000.00
MD balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 398348000.00
MD balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 425409000.00
MD cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -6728000.00
MD cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -7000000.00
MD cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -20907000.00
MD balance_sheet (quarterly, 2026-03-31) — Net Debt: 384989000.00
MD income_statement (quarterly, 2026-03-31) — Net Income: 29572000.00
MD income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 29572000.00
MD income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 29572000.00
MD income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 29572000.00
MD income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 29572000.00
MD cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 29572000.00
MD income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 29572000.00
MD income_statement (quarterly, 2026-03-31) — Net Interest Income: -8265000.00
MD cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 742000.00
MD cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -6728000.00
MD cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -6728000.00
MD income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -8265000.00
MD cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 526000.00
MD balance_sheet (quarterly, 2026-03-31) — Net PPE: 77965000.00
MD cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -6247000.00
MD balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -405609000.00
MD balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 65708000.00
MD balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 57002000.00
MD balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 65708000.00
MD balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 57002000.00
MD income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 53390000.00
MD income_statement (quarterly, 2026-03-31) — Normalized Income: 29695282.00
MD cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -129847000.00
MD income_statement (quarterly, 2026-03-31) — Operating Income: 46579000.00
MD income_statement (quarterly, 2026-03-31) — Operating Revenue: 475272000.00
MD balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 82061119.00
MD balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 8205000.00
MD balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 192421000.00
MD balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 77000.00
MD income_statement (quarterly, 2026-03-31) — Other Gand A: 60266000.00
MD income_statement (quarterly, 2026-03-31) — Other Income Expense: 530000.00
MD balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 15937000.00
MD cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -567000.00
MD balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 55403000.00
MD balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 266670000.00
MD balance_sheet (quarterly, 2026-03-31) — Other Properties: 77965000.00
MD balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 123194000.00
MD balance_sheet (quarterly, 2026-03-31) — Payables: 57426000.00
MD balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 238332000.00
MD balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
MD balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 12866000.00
MD income_statement (quarterly, 2026-03-31) — Pretax Income: 38844000.00
MD cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -7000000.00
MD cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -7008000.00
MD cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -6247000.00
MD balance_sheet (quarterly, 2026-03-31) — Receivables: 236989000.00
MD income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 363232000.00
MD income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 6119000.00
MD cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -6728000.00
MD cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -21451000.00
MD income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 4922000.00
MD balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -53580000.00
MD cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 7750000.00
MD income_statement (quarterly, 2026-03-31) — Selling General And Administration: 60266000.00
MD balance_sheet (quarterly, 2026-03-31) — Share Issued: 82061119.00
MD income_statement (quarterly, 2026-03-31) — Special Income Charges: -4922000.00
MD cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 4661000.00
MD balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 878576000.00
MD balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -405609000.00
MD income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -38718.00
MD income_statement (quarterly, 2026-03-31) — Tax Provision: 9272000.00
MD income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.24
MD balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 12188000.00
MD balance_sheet (quarterly, 2026-03-31) — Total Assets: 2070295000.00
MD balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 1276924000.00
MD balance_sheet (quarterly, 2026-03-31) — Total Debt: 629715000.00
MD balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 878576000.00
MD income_statement (quarterly, 2026-03-31) — Total Expenses: 429617000.00
MD balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1191719000.00
MD balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1483261000.00
MD balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 749081000.00
MD income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 41657000.00
MD balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 25889000.00
MD income_statement (quarterly, 2026-03-31) — Total Unusual Items: -162000.00
MD income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -162000.00
MD balance_sheet (quarterly, 2026-03-31) — Working Capital: 144396000.00
MD.V balance_sheet (annual, 2021-09-30) — Accumulated Depreciation: -59784.00
MD.V balance_sheet (annual, 2021-09-30) — Buildings And Improvements: 159422.00
MD.V balance_sheet (annual, 2021-09-30) — Cash Financial: 1490860.00
MD.V income_statement (annual, 2021-09-30) — Interest Expense: 8942.00
MD.V income_statement (annual, 2021-09-30) — Interest Expense Non Operating: 8942.00
MD.V balance_sheet (annual, 2021-09-30) — Long Term Debt And Capital Lease Obligation: 82409.00
MD.V income_statement (annual, 2022-09-30) — +Operating Expense: 1762702.00
MD.V income_statement (annual, 2022-09-30) — +Total Revenue: 210412.00
MD.V balance_sheet (annual, 2022-09-30) — Accounts Receivable: 59928.00
MD.V balance_sheet (annual, 2022-09-30) — Accumulated Depreciation: -89676.00
MD.V balance_sheet (annual, 2022-09-30) — Additional Paid In Capital: 6431575.00
MD.V cash_flow (annual, 2022-09-30) — Asset Impairment Charge: 1208289.00
MD.V balance_sheet (annual, 2022-09-30) — Available For Sale Securities: 40950.00
MD.V income_statement (annual, 2022-09-30) — Basic Average Shares: 75009762.00
MD.V income_statement (annual, 2022-09-30) — Basic EPS: -0.03
MD.V cash_flow (annual, 2022-09-30) — Beginning Cash Position: 1490860.00
MD.V balance_sheet (annual, 2022-09-30) — Buildings And Improvements: 159422.00
MD.V cash_flow (annual, 2022-09-30) — Capital Expenditure: -4121033.00
MD.V balance_sheet (annual, 2022-09-30) — Capital Lease Obligations: 82409.00
MD.V balance_sheet (annual, 2022-09-30) — Capital Stock: 52967839.00
MD.V balance_sheet (annual, 2022-09-30) — Cash And Cash Equivalents: 1895705.00
MD.V balance_sheet (annual, 2022-09-30) — Cash Cash Equivalents And Short Term Investments: 6411705.00
MD.V cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Financing Activities: 2594895.00
MD.V cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Investing Activities: -995645.00
MD.V cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Operating Activities: -1194405.00
MD.V cash_flow (annual, 2022-09-30) — Change In Other Working Capital: 224142.00
MD.V cash_flow (annual, 2022-09-30) — Change In Payables And Accrued Expense: -145787.00
MD.V cash_flow (annual, 2022-09-30) — Change In Prepaid Assets: 5321.00
MD.V cash_flow (annual, 2022-09-30) — Change In Receivables: 41032.00
MD.V cash_flow (annual, 2022-09-30) — Change In Working Capital: 124708.00
MD.V cash_flow (annual, 2022-09-30) — Changes In Account Receivables: -9800.00
MD.V cash_flow (annual, 2022-09-30) — Changes In Cash: 404845.00
MD.V balance_sheet (annual, 2022-09-30) — Common Stock: 52967839.00
MD.V balance_sheet (annual, 2022-09-30) — Common Stock Equity: 38294151.00
MD.V cash_flow (annual, 2022-09-30) — Common Stock Issuance: 2760600.00
MD.V income_statement (annual, 2022-09-30) — Cost Of Revenue: 29892.00
MD.V balance_sheet (annual, 2022-09-30) — Current Assets: 6805920.00
MD.V balance_sheet (annual, 2022-09-30) — Current Capital Lease Obligation: 31301.00
MD.V balance_sheet (annual, 2022-09-30) — Current Debt And Capital Lease Obligation: 31301.00
MD.V balance_sheet (annual, 2022-09-30) — Current Deferred Liabilities: 434135.00
MD.V balance_sheet (annual, 2022-09-30) — Current Deferred Revenue: 434135.00
MD.V balance_sheet (annual, 2022-09-30) — Current Liabilities: 870822.00
MD.V cash_flow (annual, 2022-09-30) — Deferred Income Tax: -856355.00
MD.V cash_flow (annual, 2022-09-30) — Deferred Tax: -856355.00
MD.V cash_flow (annual, 2022-09-30) — Depreciation: 29892.00
MD.V cash_flow (annual, 2022-09-30) — Depreciation Amortization Depletion: 29892.00
MD.V cash_flow (annual, 2022-09-30) — Depreciation And Amortization: 29892.00
MD.V income_statement (annual, 2022-09-30) — Diluted Average Shares: 75009762.00
MD.V income_statement (annual, 2022-09-30) — Diluted EPS: -0.03
MD.V income_statement (annual, 2022-09-30) — Diluted NI Availto Com Stockholders: -1900085.00
MD.V income_statement (annual, 2022-09-30) — EBIT: -1582182.00
MD.V income_statement (annual, 2022-09-30) — EBITDA: -1552290.00
MD.V cash_flow (annual, 2022-09-30) — End Cash Position: 1895705.00
MD.V cash_flow (annual, 2022-09-30) — Financing Cash Flow: 2594895.00
MD.V cash_flow (annual, 2022-09-30) — Free Cash Flow: -5315438.00
MD.V income_statement (annual, 2022-09-30) — Gain On Sale Of Security: -39631.00
MD.V income_statement (annual, 2022-09-30) — General And Administrative Expense: 1237753.00
MD.V balance_sheet (annual, 2022-09-30) — Gross PPE: 32319211.00
MD.V income_statement (annual, 2022-09-30) — Gross Profit: 180520.00
MD.V income_statement (annual, 2022-09-30) — Impairment Of Capital Assets: 1208289.00
MD.V income_statement (annual, 2022-09-30) — Interest Expense: 6862.00
MD.V income_statement (annual, 2022-09-30) — Interest Expense Non Operating: 6862.00
MD.V income_statement (annual, 2022-09-30) — Interest Income: 80524.00
MD.V income_statement (annual, 2022-09-30) — Interest Income Non Operating: 80524.00
MD.V balance_sheet (annual, 2022-09-30) — Invested Capital: 38294151.00
MD.V cash_flow (annual, 2022-09-30) — Investing Cash Flow: -995645.00
MD.V balance_sheet (annual, 2022-09-30) — Investmentin Financial Assets: 40950.00
MD.V balance_sheet (annual, 2022-09-30) — Investments And Advances: 40950.00
MD.V cash_flow (annual, 2022-09-30) — Issuance Of Capital Stock: 2760600.00
MD.V balance_sheet (annual, 2022-09-30) — Long Term Capital Lease Obligation: 51108.00
MD.V balance_sheet (annual, 2022-09-30) — Long Term Debt And Capital Lease Obligation: 51108.00
MD.V cash_flow (annual, 2022-09-30) — Long Term Debt Payments: -28341.00
MD.V cash_flow (annual, 2022-09-30) — Net Common Stock Issuance: 2760600.00
MD.V income_statement (annual, 2022-09-30) — Net Income: -1900085.00
MD.V income_statement (annual, 2022-09-30) — Net Income Common Stockholders: -1900085.00
MD.V income_statement (annual, 2022-09-30) — Net Income Continuous Operations: -1900085.00
MD.V income_statement (annual, 2022-09-30) — Net Income From Continuing And Discontinued Operation: -1900085.00
MD.V income_statement (annual, 2022-09-30) — Net Income From Continuing Operation Net Minority Interest: -1900085.00
MD.V cash_flow (annual, 2022-09-30) — Net Income From Continuing Operations: -1900085.00
MD.V income_statement (annual, 2022-09-30) — Net Income Including Noncontrolling Interests: -1900085.00
MD.V income_statement (annual, 2022-09-30) — Net Interest Income: 73662.00
MD.V cash_flow (annual, 2022-09-30) — Net Investment Purchase And Sale: 1514387.00
MD.V cash_flow (annual, 2022-09-30) — Net Issuance Payments Of Debt: -28341.00
MD.V cash_flow (annual, 2022-09-30) — Net Long Term Debt Issuance: -28341.00
MD.V income_statement (annual, 2022-09-30) — Net Non Operating Interest Income Expense: 73662.00
MD.V cash_flow (annual, 2022-09-30) — Net Other Financing Charges: -137364.00
MD.V cash_flow (annual, 2022-09-30) — Net Other Investing Changes: 1331001.00
MD.V balance_sheet (annual, 2022-09-30) — Net PPE: 32319211.00
MD.V cash_flow (annual, 2022-09-30) — Net PPE Purchase And Sale: -3841033.00
MD.V balance_sheet (annual, 2022-09-30) — Net Tangible Assets: 38294151.00
MD.V balance_sheet (annual, 2022-09-30) — Non Current Prepaid Assets: 50000.00
MD.V income_statement (annual, 2022-09-30) — Normalized EBITDA: -304370.00
MD.V income_statement (annual, 2022-09-30) — Normalized Income: -1039861.64
MD.V cash_flow (annual, 2022-09-30) — Operating Cash Flow: -1194405.00
MD.V income_statement (annual, 2022-09-30) — Operating Income: -1582182.00
MD.V income_statement (annual, 2022-09-30) — Operating Revenue: 210412.00
MD.V balance_sheet (annual, 2022-09-30) — Ordinary Shares Number: 75667797.00
MD.V balance_sheet (annual, 2022-09-30) — Other Current Liabilities: 113480.00
MD.V income_statement (annual, 2022-09-30) — Other Gand A: 304373.00
MD.V income_statement (annual, 2022-09-30) — Other Income Expense: -1247920.00
MD.V balance_sheet (annual, 2022-09-30) — Other Investments: 0.00
MD.V income_statement (annual, 2022-09-30) — Other Operating Expenses: 524949.00
MD.V balance_sheet (annual, 2022-09-30) — Other Properties: 32319211.00
MD.V balance_sheet (annual, 2022-09-30) — Other Short Term Investments: 4516000.00
MD.V balance_sheet (annual, 2022-09-30) — Payables And Accrued Expenses: 291906.00
MD.V balance_sheet (annual, 2022-09-30) — Prepaid Assets: 54861.00
MD.V income_statement (annual, 2022-09-30) — Pretax Income: -2756440.00
MD.V cash_flow (annual, 2022-09-30) — Purchase Of Investment: -4504000.00
MD.V cash_flow (annual, 2022-09-30) — Purchase Of PPE: -4121033.00
MD.V balance_sheet (annual, 2022-09-30) — Receivables: 339354.00
MD.V income_statement (annual, 2022-09-30) — Reconciled Cost Of Revenue: 29892.00
MD.V income_statement (annual, 2022-09-30) — Reconciled Depreciation: 29892.00
MD.V cash_flow (annual, 2022-09-30) — Repayment Of Debt: -28341.00
MD.V balance_sheet (annual, 2022-09-30) — Retained Earnings: -21105263.00
MD.V income_statement (annual, 2022-09-30) — Salaries And Wages: 933380.00
MD.V cash_flow (annual, 2022-09-30) — Sale Of Investment: 6018387.00
MD.V cash_flow (annual, 2022-09-30) — Sale Of PPE: 280000.00
MD.V income_statement (annual, 2022-09-30) — Selling General And Administration: 1237753.00
MD.V balance_sheet (annual, 2022-09-30) — Share Issued: 75667797.00
MD.V income_statement (annual, 2022-09-30) — Special Income Charges: -1208289.00
MD.V cash_flow (annual, 2022-09-30) — Stock Based Compensation: 159515.00
MD.V balance_sheet (annual, 2022-09-30) — Stockholders Equity: 38294151.00
MD.V balance_sheet (annual, 2022-09-30) — Tangible Book Value: 38294151.00
MD.V income_statement (annual, 2022-09-30) — Tax Effect Of Unusual Items: -387696.64
MD.V income_statement (annual, 2022-09-30) — Tax Provision: -856355.00
MD.V income_statement (annual, 2022-09-30) — Tax Rate For Calcs: 0.31
MD.V balance_sheet (annual, 2022-09-30) — Taxes Receivable: 279426.00
MD.V balance_sheet (annual, 2022-09-30) — Total Assets: 39216081.00
MD.V balance_sheet (annual, 2022-09-30) — Total Capitalization: 38294151.00
MD.V balance_sheet (annual, 2022-09-30) — Total Debt: 82409.00
MD.V balance_sheet (annual, 2022-09-30) — Total Equity Gross Minority Interest: 38294151.00
MD.V income_statement (annual, 2022-09-30) — Total Expenses: 1792594.00
MD.V balance_sheet (annual, 2022-09-30) — Total Liabilities Net Minority Interest: 921930.00
MD.V balance_sheet (annual, 2022-09-30) — Total Non Current Assets: 32410161.00
MD.V balance_sheet (annual, 2022-09-30) — Total Non Current Liabilities Net Minority Interest: 51108.00
MD.V income_statement (annual, 2022-09-30) — Total Other Finance Cost: 6862.00
MD.V income_statement (annual, 2022-09-30) — Total Unusual Items: -1247920.00
MD.V income_statement (annual, 2022-09-30) — Total Unusual Items Excluding Goodwill: -1247920.00
MD.V cash_flow (annual, 2022-09-30) — Unrealized Gain Loss On Investment Securities: 39631.00
MD.V balance_sheet (annual, 2022-09-30) — Working Capital: 5935098.00
MD.V income_statement (annual, 2023-09-30) — +Operating Expense: 1832768.00
MD.V income_statement (annual, 2023-09-30) — +Total Revenue: 314971.00
MD.V balance_sheet (annual, 2023-09-30) — Accounts Receivable: 224947.00
MD.V balance_sheet (annual, 2023-09-30) — Additional Paid In Capital: 6633446.00
MD.V cash_flow (annual, 2023-09-30) — Asset Impairment Charge: 976731.00
MD.V balance_sheet (annual, 2023-09-30) — Available For Sale Securities: 144131.00
MD.V income_statement (annual, 2023-09-30) — Basic Average Shares: 81689477.00
MD.V income_statement (annual, 2023-09-30) — Basic EPS: -0.01
MD.V cash_flow (annual, 2023-09-30) — Beginning Cash Position: 1895705.00
MD.V cash_flow (annual, 2023-09-30) — Capital Expenditure: -4171860.00
MD.V balance_sheet (annual, 2023-09-30) — Capital Lease Obligations: 51108.00
MD.V balance_sheet (annual, 2023-09-30) — Capital Stock: 55568556.00
MD.V balance_sheet (annual, 2023-09-30) — Cash And Cash Equivalents: 2453793.00
MD.V balance_sheet (annual, 2023-09-30) — Cash Cash Equivalents And Short Term Investments: 4960793.00
MD.V cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Financing Activities: 3389520.00
MD.V cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Investing Activities: -2366715.00
MD.V cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Operating Activities: -464717.00
MD.V cash_flow (annual, 2023-09-30) — Change In Other Working Capital: 285861.00
MD.V cash_flow (annual, 2023-09-30) — Change In Payables And Accrued Expense: 618221.00
MD.V cash_flow (annual, 2023-09-30) — Change In Prepaid Assets: -47292.00
MD.V cash_flow (annual, 2023-09-30) — Change In Receivables: -192780.00
MD.V cash_flow (annual, 2023-09-30) — Change In Working Capital: 664010.00
MD.V cash_flow (annual, 2023-09-30) — Changes In Account Receivables: -165019.00
MD.V cash_flow (annual, 2023-09-30) — Changes In Cash: 558088.00
MD.V balance_sheet (annual, 2023-09-30) — Common Stock: 55568556.00
MD.V balance_sheet (annual, 2023-09-30) — Common Stock Equity: 39781064.00
MD.V cash_flow (annual, 2023-09-30) — Common Stock Issuance: 3627280.00
MD.V income_statement (annual, 2023-09-30) — Cost Of Revenue: 29892.00
MD.V balance_sheet (annual, 2023-09-30) — Current Assets: 5678842.00
MD.V balance_sheet (annual, 2023-09-30) — Current Capital Lease Obligation: 34496.00
MD.V balance_sheet (annual, 2023-09-30) — Current Debt And Capital Lease Obligation: 34496.00
MD.V balance_sheet (annual, 2023-09-30) — Current Deferred Liabilities: 719996.00
MD.V balance_sheet (annual, 2023-09-30) — Current Deferred Revenue: 719996.00
MD.V balance_sheet (annual, 2023-09-30) — Current Liabilities: 1865393.00
MD.V cash_flow (annual, 2023-09-30) — Deferred Income Tax: -1140043.00
MD.V cash_flow (annual, 2023-09-30) — Deferred Tax: -1140043.00
MD.V cash_flow (annual, 2023-09-30) — Depreciation: 29892.00
MD.V cash_flow (annual, 2023-09-30) — Depreciation Amortization Depletion: 29892.00
MD.V cash_flow (annual, 2023-09-30) — Depreciation And Amortization: 29892.00
MD.V income_statement (annual, 2023-09-30) — Diluted Average Shares: 81689477.00
MD.V income_statement (annual, 2023-09-30) — Diluted EPS: -0.01
MD.V income_statement (annual, 2023-09-30) — Diluted NI Availto Com Stockholders: -1109216.00
MD.V income_statement (annual, 2023-09-30) — EBIT: -1547689.00
MD.V income_statement (annual, 2023-09-30) — EBITDA: -1517797.00
MD.V cash_flow (annual, 2023-09-30) — End Cash Position: 2453793.00
MD.V cash_flow (annual, 2023-09-30) — Financing Cash Flow: 3389520.00
MD.V cash_flow (annual, 2023-09-30) — Free Cash Flow: -4636577.00
MD.V income_statement (annual, 2023-09-30) — Gain On Sale Of Security: 28911.00
MD.V income_statement (annual, 2023-09-30) — General And Administrative Expense: 1324243.00
MD.V balance_sheet (annual, 2023-09-30) — Gross PPE: 35040096.00
MD.V income_statement (annual, 2023-09-30) — Gross Profit: 285079.00
MD.V income_statement (annual, 2023-09-30) — Impairment Of Capital Assets: 976731.00
MD.V income_statement (annual, 2023-09-30) — Interest Income: 251035.00
MD.V income_statement (annual, 2023-09-30) — Interest Income Non Operating: 251035.00
MD.V balance_sheet (annual, 2023-09-30) — Invested Capital: 39781064.00
MD.V cash_flow (annual, 2023-09-30) — Investing Cash Flow: -2366715.00
MD.V balance_sheet (annual, 2023-09-30) — Investmentin Financial Assets: 144131.00
MD.V balance_sheet (annual, 2023-09-30) — Investments And Advances: 944131.00
MD.V cash_flow (annual, 2023-09-30) — Issuance Of Capital Stock: 3627280.00
MD.V balance_sheet (annual, 2023-09-30) — Long Term Capital Lease Obligation: 16612.00
MD.V balance_sheet (annual, 2023-09-30) — Long Term Debt And Capital Lease Obligation: 16612.00
MD.V cash_flow (annual, 2023-09-30) — Long Term Debt Payments: -31301.00
MD.V cash_flow (annual, 2023-09-30) — Net Common Stock Issuance: 3627280.00
MD.V income_statement (annual, 2023-09-30) — Net Income: -1109216.00
MD.V income_statement (annual, 2023-09-30) — Net Income Common Stockholders: -1109216.00
MD.V income_statement (annual, 2023-09-30) — Net Income Continuous Operations: -1109216.00
MD.V income_statement (annual, 2023-09-30) — Net Income From Continuing And Discontinued Operation: -1109216.00
MD.V income_statement (annual, 2023-09-30) — Net Income From Continuing Operation Net Minority Interest: -1109216.00
MD.V cash_flow (annual, 2023-09-30) — Net Income From Continuing Operations: -1109216.00
MD.V income_statement (annual, 2023-09-30) — Net Income Including Noncontrolling Interests: -1109216.00
MD.V income_statement (annual, 2023-09-30) — Net Interest Income: 246250.00
MD.V cash_flow (annual, 2023-09-30) — Net Investment Purchase And Sale: 1259730.00
MD.V cash_flow (annual, 2023-09-30) — Net Issuance Payments Of Debt: -31301.00
MD.V cash_flow (annual, 2023-09-30) — Net Long Term Debt Issuance: -31301.00
MD.V income_statement (annual, 2023-09-30) — Net Non Operating Interest Income Expense: 246250.00
MD.V cash_flow (annual, 2023-09-30) — Net Other Financing Charges: -206459.00
MD.V cash_flow (annual, 2023-09-30) — Net Other Investing Changes: 220415.00
MD.V balance_sheet (annual, 2023-09-30) — Net PPE: 35040096.00
MD.V cash_flow (annual, 2023-09-30) — Net PPE Purchase And Sale: -3846860.00
MD.V balance_sheet (annual, 2023-09-30) — Net Tangible Assets: 39781064.00
MD.V balance_sheet (annual, 2023-09-30) — Non Current Prepaid Assets: 0.00
MD.V income_statement (annual, 2023-09-30) — Normalized EBITDA: -569977.00
MD.V income_statement (annual, 2023-09-30) — Normalized Income: -540524.00
MD.V cash_flow (annual, 2023-09-30) — Operating Cash Flow: -464717.00
MD.V income_statement (annual, 2023-09-30) — Operating Income: -1547689.00
MD.V income_statement (annual, 2023-09-30) — Operating Revenue: 314971.00
MD.V balance_sheet (annual, 2023-09-30) — Ordinary Shares Number: 82776197.00
MD.V income_statement (annual, 2023-09-30) — Other Gand A: 414018.00
MD.V income_statement (annual, 2023-09-30) — Other Income Expense: -947820.00
MD.V balance_sheet (annual, 2023-09-30) — Other Investments: 800000.00
MD.V income_statement (annual, 2023-09-30) — Other Operating Expenses: 508525.00
MD.V balance_sheet (annual, 2023-09-30) — Other Properties: 35040096.00
MD.V balance_sheet (annual, 2023-09-30) — Other Short Term Investments: 2507000.00
MD.V balance_sheet (annual, 2023-09-30) — Payables And Accrued Expenses: 1110901.00
MD.V balance_sheet (annual, 2023-09-30) — Prepaid Assets: 102153.00
MD.V income_statement (annual, 2023-09-30) — Pretax Income: -2249259.00
MD.V cash_flow (annual, 2023-09-30) — Purchase Of Investment: -3300000.00
MD.V cash_flow (annual, 2023-09-30) — Purchase Of PPE: -4171860.00
MD.V balance_sheet (annual, 2023-09-30) — Receivables: 615896.00
MD.V income_statement (annual, 2023-09-30) — Reconciled Cost Of Revenue: 29892.00
MD.V income_statement (annual, 2023-09-30) — Reconciled Depreciation: 29892.00
MD.V cash_flow (annual, 2023-09-30) — Repayment Of Debt: -31301.00
MD.V balance_sheet (annual, 2023-09-30) — Retained Earnings: -22420938.00
MD.V income_statement (annual, 2023-09-30) — Salaries And Wages: 910225.00
MD.V cash_flow (annual, 2023-09-30) — Sale Of Investment: 4559730.00
MD.V cash_flow (annual, 2023-09-30) — Sale Of PPE: 325000.00
MD.V income_statement (annual, 2023-09-30) — Selling General And Administration: 1324243.00
MD.V balance_sheet (annual, 2023-09-30) — Share Issued: 82776197.00
MD.V income_statement (annual, 2023-09-30) — Special Income Charges: -976731.00
MD.V cash_flow (annual, 2023-09-30) — Stock Based Compensation: 142820.00
MD.V balance_sheet (annual, 2023-09-30) — Stockholders Equity: 39781064.00
MD.V balance_sheet (annual, 2023-09-30) — Tangible Book Value: 39781064.00
MD.V income_statement (annual, 2023-09-30) — Tax Effect Of Unusual Items: -379128.00
MD.V income_statement (annual, 2023-09-30) — Tax Provision: -1140043.00
MD.V income_statement (annual, 2023-09-30) — Tax Rate For Calcs: 0.40
MD.V balance_sheet (annual, 2023-09-30) — Taxes Receivable: 390949.00
MD.V balance_sheet (annual, 2023-09-30) — Total Assets: 41663069.00
MD.V balance_sheet (annual, 2023-09-30) — Total Capitalization: 39781064.00
MD.V balance_sheet (annual, 2023-09-30) — Total Debt: 51108.00
MD.V balance_sheet (annual, 2023-09-30) — Total Equity Gross Minority Interest: 39781064.00
MD.V income_statement (annual, 2023-09-30) — Total Expenses: 1862660.00
MD.V balance_sheet (annual, 2023-09-30) — Total Liabilities Net Minority Interest: 1882005.00
MD.V balance_sheet (annual, 2023-09-30) — Total Non Current Assets: 35984227.00
MD.V balance_sheet (annual, 2023-09-30) — Total Non Current Liabilities Net Minority Interest: 16612.00
MD.V income_statement (annual, 2023-09-30) — Total Other Finance Cost: 4785.00
MD.V income_statement (annual, 2023-09-30) — Total Unusual Items: -947820.00
MD.V income_statement (annual, 2023-09-30) — Total Unusual Items Excluding Goodwill: -947820.00
MD.V cash_flow (annual, 2023-09-30) — Unrealized Gain Loss On Investment Securities: -28911.00
MD.V balance_sheet (annual, 2023-09-30) — Working Capital: 3813449.00
MD.V income_statement (annual, 2024-09-30) — +Operating Expense: 2102789.00
MD.V income_statement (annual, 2024-09-30) — +Total Revenue: 194949.00
MD.V balance_sheet (annual, 2024-09-30) — Accounts Receivable: 197742.00
MD.V balance_sheet (annual, 2024-09-30) — Additional Paid In Capital: 6840786.00
MD.V cash_flow (annual, 2024-09-30) — Asset Impairment Charge: 1349257.00
MD.V balance_sheet (annual, 2024-09-30) — Available For Sale Securities: 205700.00
MD.V balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 205700.00
MD.V income_statement (annual, 2024-09-30) — Basic Average Shares: 86315245.00
MD.V income_statement (annual, 2024-09-30) — Basic EPS: -0.02
MD.V cash_flow (annual, 2024-09-30) — Beginning Cash Position: 2453793.00
MD.V cash_flow (annual, 2024-09-30) — Capital Expenditure: -2924479.00
MD.V balance_sheet (annual, 2024-09-30) — Capital Lease Obligations: 16612.00
MD.V balance_sheet (annual, 2024-09-30) — Capital Stock: 57236502.00
MD.V balance_sheet (annual, 2024-09-30) — Cash And Cash Equivalents: 1590510.00
MD.V balance_sheet (annual, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 4780991.00
MD.V cash_flow (annual, 2024-09-30) — Cash Flow From Continuing Financing Activities: 2479092.00
MD.V cash_flow (annual, 2024-09-30) — Cash Flow From Continuing Investing Activities: -1745044.00
MD.V cash_flow (annual, 2024-09-30) — Cash Flow From Continuing Operating Activities: -1597331.00
MD.V cash_flow (annual, 2024-09-30) — Change In Other Working Capital: 369497.00
MD.V cash_flow (annual, 2024-09-30) — Change In Payables And Accrued Expense: -511918.00
MD.V cash_flow (annual, 2024-09-30) — Change In Prepaid Assets: -3410.00
MD.V cash_flow (annual, 2024-09-30) — Change In Receivables: -1460.00
MD.V cash_flow (annual, 2024-09-30) — Change In Working Capital: -147291.00
MD.V cash_flow (annual, 2024-09-30) — Changes In Account Receivables: 27205.00
MD.V cash_flow (annual, 2024-09-30) — Changes In Cash: -863283.00
MD.V balance_sheet (annual, 2024-09-30) — Common Stock: 57236502.00
MD.V balance_sheet (annual, 2024-09-30) — Common Stock Equity: 39521994.00
MD.V cash_flow (annual, 2024-09-30) — Common Stock Issuance: 2694798.00
MD.V income_statement (annual, 2024-09-30) — Cost Of Revenue: 29892.00
MD.V balance_sheet (annual, 2024-09-30) — Current Assets: 5296181.00
MD.V balance_sheet (annual, 2024-09-30) — Current Capital Lease Obligation: 16612.00
MD.V balance_sheet (annual, 2024-09-30) — Current Debt And Capital Lease Obligation: 16612.00
MD.V balance_sheet (annual, 2024-09-30) — Current Deferred Liabilities: 1089493.00
MD.V balance_sheet (annual, 2024-09-30) — Current Deferred Revenue: 1089493.00
MD.V balance_sheet (annual, 2024-09-30) — Current Liabilities: 1698330.00
MD.V cash_flow (annual, 2024-09-30) — Deferred Income Tax: -1026852.00
MD.V cash_flow (annual, 2024-09-30) — Deferred Tax: -1026852.00
MD.V cash_flow (annual, 2024-09-30) — Depreciation: 29892.00
MD.V cash_flow (quarterly, 2024-09-30) — Depreciation: 7473.00
MD.V cash_flow (annual, 2024-09-30) — Depreciation Amortization Depletion: 29892.00
MD.V cash_flow (annual, 2024-09-30) — Depreciation And Amortization: 29892.00
MD.V income_statement (annual, 2024-09-30) — Diluted Average Shares: 86315245.00
MD.V income_statement (annual, 2024-09-30) — Diluted EPS: -0.02
MD.V income_statement (annual, 2024-09-30) — Diluted NI Availto Com Stockholders: -1953146.00
MD.V income_statement (annual, 2024-09-30) — EBIT: -1937732.00
MD.V income_statement (annual, 2024-09-30) — EBITDA: -1907840.00
MD.V cash_flow (annual, 2024-09-30) — End Cash Position: 1590510.00
MD.V cash_flow (annual, 2024-09-30) — Financing Cash Flow: 2479092.00
MD.V cash_flow (annual, 2024-09-30) — Free Cash Flow: -4521810.00
MD.V income_statement (annual, 2024-09-30) — Gain On Sale Of Security: -2191.00
MD.V income_statement (annual, 2024-09-30) — General And Administrative Expense: 1394365.00
MD.V balance_sheet (annual, 2024-09-30) — Gross PPE: 35218443.00
MD.V income_statement (annual, 2024-09-30) — Gross Profit: 165057.00
MD.V income_statement (annual, 2024-09-30) — Impairment Of Capital Assets: 1349257.00
MD.V income_statement (annual, 2024-09-30) — Interest Income: 311674.00
MD.V income_statement (annual, 2024-09-30) — Interest Income Non Operating: 311674.00
MD.V balance_sheet (annual, 2024-09-30) — Invested Capital: 39521994.00
MD.V cash_flow (annual, 2024-09-30) — Investing Cash Flow: -1745044.00
MD.V balance_sheet (annual, 2024-09-30) — Investmentin Financial Assets: 205700.00
MD.V balance_sheet (annual, 2024-09-30) — Investments And Advances: 705700.00
MD.V cash_flow (annual, 2024-09-30) — Issuance Of Capital Stock: 2694798.00
MD.V balance_sheet (annual, 2024-09-30) — Long Term Capital Lease Obligation: 0.00
MD.V cash_flow (annual, 2024-09-30) — Long Term Debt Payments: -34496.00
MD.V cash_flow (annual, 2024-09-30) — Net Common Stock Issuance: 2694798.00
MD.V income_statement (annual, 2024-09-30) — Net Income: -1953146.00
MD.V income_statement (annual, 2024-09-30) — Net Income Common Stockholders: -1953146.00
MD.V income_statement (annual, 2024-09-30) — Net Income Continuous Operations: -1953146.00
MD.V income_statement (annual, 2024-09-30) — Net Income From Continuing And Discontinued Operation: -1953146.00
MD.V income_statement (annual, 2024-09-30) — Net Income From Continuing Operation Net Minority Interest: -1953146.00
MD.V cash_flow (annual, 2024-09-30) — Net Income From Continuing Operations: -1953146.00
MD.V income_statement (annual, 2024-09-30) — Net Income Including Noncontrolling Interests: -1953146.00
MD.V income_statement (annual, 2024-09-30) — Net Interest Income: 309182.00
MD.V cash_flow (annual, 2024-09-30) — Net Investment Purchase And Sale: -272241.00
MD.V cash_flow (annual, 2024-09-30) — Net Issuance Payments Of Debt: -34496.00
MD.V cash_flow (annual, 2024-09-30) — Net Long Term Debt Issuance: -34496.00
MD.V income_statement (annual, 2024-09-30) — Net Non Operating Interest Income Expense: 309182.00
MD.V cash_flow (annual, 2024-09-30) — Net Other Financing Charges: -181210.00
MD.V cash_flow (annual, 2024-09-30) — Net Other Investing Changes: 321676.00
MD.V balance_sheet (annual, 2024-09-30) — Net PPE: 35218443.00
MD.V cash_flow (annual, 2024-09-30) — Net PPE Purchase And Sale: -1794479.00
MD.V balance_sheet (annual, 2024-09-30) — Net Tangible Assets: 39521994.00
MD.V balance_sheet (annual, 2024-09-30) — Non Current Prepaid Assets: 0.00
MD.V balance_sheet (quarterly, 2024-09-30) — Non Current Prepaid Assets: 0.00
MD.V income_statement (annual, 2024-09-30) — Normalized EBITDA: -556392.00
MD.V income_statement (annual, 2024-09-30) — Normalized Income: -1067381.90
MD.V cash_flow (annual, 2024-09-30) — Operating Cash Flow: -1597331.00
MD.V income_statement (annual, 2024-09-30) — Operating Income: -1937732.00
MD.V income_statement (annual, 2024-09-30) — Operating Revenue: 194949.00